Claims
- 1. A method of treating epilepsy in a person in need thereof, comprising administering an effective amount of a compound, wherein the compound is selected from the group consisting of:
- 2-chloro-N-(1-phenoxy-2-propyl)adenosine;
- 2-chloro-N-�(R)-1-phenoxy-2-propyl!adenosine;
- 2-chloro-N-(2-phenoxyethyl)adenosine;
- 2-chloro-N-(1-phenyl-3-butyl)adenosine;
- 2-amino-N-(1-phenoxy-2-propyl)adenosine;
- 2-chloro-N-(cis-2-phenoxycyclopentyl)adenosine;
- 2-chloro-N-(trans-2-phenoxycyclopentyl)adenosine;
- 2-chloro-N-�(R)-1-phenylthio-2-propyl!adenosine;
- (R)-2-chloro-N-�1-(4-fluorophenoxy)-2-propyl!adenosine;
- 2-methoxy-N-�(R)-1-phenoxy-2-propyl!adenosine;
- 2-methyl-N-�(R)-1-phenoxy-2-propyl!adenosine; and pharmaceutically acceptable salts thereof.
- 2. A method according to claim 1, wherein the compound is 2-chloro-N-(1-phenoxy-2-propyl)adenosine or a pharmaceutically acceptable salt thereof.
- 3. A method according to claim 1, wherein the compound is 2-chloro-N-�(R)-1-phenoxy-2-propyl!adenosine or a pharmaceutically acceptable salt thereof.
- 4. A method according to claim 1, wherein the compound is 2-chloro-N-(2-phenoxyethyl)adenosine or a pharmaceutically acceptable salt thereof.
- 5. A method according to claim 1, wherein the compound is 2-chloro-N-(1-phenyl-3-butyl)adenosine or a pharmaceutically acceptable salt thereof.
- 6. A method according to claim 1, wherein the compound is 2-amino-N-(1-phenoxy-2-propyl)adenosine or a pharmaceutically acceptable salt thereof.
- 7. A method according to claim 1, wherein the compound is 2-chloro-N-(cis-2-phenoxycyclopentyl)adenosine or a pharmaceutically acceptable salt thereof.
- 8. A method according to claim 1, wherein the compound is 2-chloro-N-(trans-2-phenoxycyclopentyl)adenosine or a pharmaceutically acceptable salt thereof.
- 9. A method according to claim 1, wherein the compound is 2-chloro-N-�(R)-1-phenylthio-2-propyl!adenosine or a pharmaceutically acceptable salt thereof.
- 10. A method according to claim 1, wherein the compound is (R)-2-chloro-N-�1-(4-fluorophenoxy)-2-propyl!adenosine or a pharmaceutically acceptable salt thereof.
- 11. A method according to claim 1, wherein the compound is 2-methoxy-N-�(R)-1-phenoxy-2-propyl!adenosine or a pharmaceutically acceptable salt thereof.
- 12. A method according to claim 1, wherein the compound is 2-methyl-N-�(R)-1-phenoxy-2-propyl!adenosine or a pharmaceutically acceptable salt thereof.
Parent Case Info
This application is a continuation of application Ser. No. 08/348,785 filed Dec. 2, 1994 now abandoned, which is a continuation application of application Ser. No. 08/060,784, filed May 12, 1993 now abandoned, which is a continuation-in-part of Ser. No. 07/886,534 filed May 20, 1992, now abandoned, the contents of which are incorporated herein by reference.
US Referenced Citations (4)
Foreign Referenced Citations (3)
Number |
Date |
Country |
0322242 |
Jun 1989 |
EPX |
1123245 |
Aug 1968 |
GBX |
1143150 |
Feb 1969 |
GBX |
Non-Patent Literature Citations (2)
Entry |
Kusachi et al., J. Med. Chem., vol. 29, pp. 989-996 (1986). |
Daly et al., Biochemical Pharmacology, vol. 35, No. 15, pp. 2467-2481 (1986). |
Continuations (2)
|
Number |
Date |
Country |
Parent |
348785 |
Dec 1994 |
|
Parent |
60784 |
May 1993 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
886534 |
May 1992 |
|